Opendata, web and dolomites
H2020 projects about "t2d"
The page lists 35 projects related to the topic "t2d".
| # | |||
|---|---|---|---|
| 1 | iHealth-T2D | Family-based intervention to improve healthy lifestyle and prevent Type 2 Diabetes amongst South Asians with central obesity and prediabetes | 2015 |
| 2 | GLUCOTOX | Does reducing β-cell glucotoxicity increase the hyperglycaemia-lowering effect of physical exercise in type 2 diabetes? | 2015 |
| 3 | 3D-ADAPT | Analysis of tridimensional changes caused by type 2 Diabetes-Associated varianTs | 2015 |
| 4 | BIOMENDELIAN | Linking Cardiometabolic Disease and Cancer in the Level of Genetics, Circulating Biomarkers, Microbiota and Environmental Risk Factors | 2015 |
| 5 | T2DSystems | Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes | 2016 |
| 6 | INTERPLAY | Interplay between genetic determinants of glycaemia, type 2 diabetes and cardiovascular disease in interaction with dietary and lifestyle factors | 2017 |
| 7 | NUTBIO-DIAB | Nutritional biomarkers to advance understanding of association between diet and type 2 diabetes | 2016 |
| 8 | SiCMetabol | Signaling Cascades in Metabolic Diseases | 2016 |
| 9 | TSGPs-of-CFSs | Role of Tumour Suppressor Gene Products of Common Fragile Sites in Human Diseases | 2016 |
| 10 | EpiHope | Epigenetic biomarkers for prediction of vascular complications and response to treatment in subjects with diabetes | 2016 |
| 11 | TransGen RNA | Transgenerational regulation of glucose metabolism by noncoding RNAs | 2016 |
| 12 | SMILED | Skeletal Muscle Inflammation: ambivalent roles in Exercise and Diabetes | 2016 |
| 13 | ImmunoBile | Bile acid, immune-metabolism, lipid and glucose homeostasis | 2016 |
| 14 | Fit-The-Fat | IMMUNOMETABOLISM IN HUMAN OBESITY | 2017 |
| 15 | MusEC | UNDERSTANDING THE METABOLIC CROSSTALK BETWEEN THE MUSCLE AND THE ENDOTHELIUM: IMPLICATIONS FOR EXERCISE TRAINING AND INSULIN RESISTANCE | 2017 |
| 16 | BETA-BACT | Beta-cell inflammation and dysfunction induced by bacterial translocation | 2016 |
| 17 | DAMOC | Diabetes Approach by Multi-Organ-on-a-Chip | 2017 |
| 18 | Reg-Seq | Functional genomics of non-coding mutations in regulatory regions of four metabolic tissues, and their involvement into type 2 diabetes through large-scale sequencing | 2017 |
| 19 | AMPK-DIAB | A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novelinnovative drug for the treatment of type 2 diabetes | 2016 |
| 20 | MITOSENSING | Decoding mitochondrial nutrient-sensing programs in POMC neurons as key determinants of metabolic health | 2017 |
| 21 | LiSDMA | Liver steatosis drives muscle atrophy in type 2 diabetes patients. | 2018 |
| 22 | RHAPSODY | Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 | 2016 |
| 23 | EpiFAT | Epigenomic Reprogramming of Adipose Tissue Function and Energy Metabolism in Type 2 Diabetes | 2017 |
| 24 | PAINTBOX | Pancreatic islet dysfunction and type 2 diabetes – beyond the genome | 2017 |
| 25 | ExoDia | Cross-talk between skeletal muscle and pancreatic islets: impact of exosomes | 2018 |
| 26 | NACHO | Nicotine actions on beta cell function in health and disease | 2018 |
| 27 | INSULYSOSOME | The role of CD63 in lysosomal degradation of insulin granules in pancreatic beta cells in T2D diabetes | 2018 |
| 28 | SCUBY | SCale Up an integrated care package for diaBetes and hYpertension for vulnerable people in Cambodia, Slovenia and Belgium | 2019 |
| 29 | ECHO | Early conditions, delayed adult effects and morbidity, disability and mortality in modern human populations | 2019 |
| 30 | XEND | Clinical assessment of PILA PHARMA’s TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent | 2019 |
| 31 | REMAKIN | REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion. | 2019 |
| 32 | EASY-Diabetes | Individualised and Equitable Care of Type 2 Diabetes | 2019 |
| 33 | RECOGNISED | Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia | 2020 |
| 34 | TRANSLATIONAL | A new translational strategy for tailored treatment of type 2 diabetes | 2020 |
| 35 | CAPTUR3D | CAPTURING THE PHYSICS OF LIFE ON 3D-TRAFFICKING SUBCELLULAR NANOSYSTEMS | 2020 |